NNI in the News

Archive of news stories highlighted on nano.gov's homepage.
August 20, 2020
Researchers have demonstrated a new way to precisely target cells by using nanoscale devices made of synthetic proteins that target a therapeutic agent only to cells with specific, predetermined combinations of cell surface markers.
August 06, 2020
Researchers have developed a method that combines high-precision protein measurement with sticky nanoparticles to capture and analyze a common marker of heart disease and to reveal details that were previously inaccessible.
July 23, 2020
Researchers have designed a computational system to screen twisted multi-layer graphene stacks for twist angles associated with potentially interesting electronic properties.
July 21, 2020
Engineers have devised a method that uses nanoparticles, called gold nanostars, to help identify early biomarkers of cancer without the need for the elaborate, time-consuming, and expensive processes required by current technologies.
July 20, 2020
Researchers have demonstrated that spheres made of bismuth, oxygen, and carbon wrapped with nitrogen-doped graphene oxide can inactivate multidrug-resistant bacteria and degrade antibiotic-resistant genes in secondary wastewater effluent.
July 20, 2020
Using specialized nanoparticles, engineers have developed a way to monitor pneumonia by analyzing the breath exhaled by the patient.
July 19, 2020
Researchers have found a new method for inducing mechanical stimulation of neurons in the body with nanoparticles that are activated through a magnetic field.
July 15, 2020
Researchers have created a less expensive 3D printing method on the nanoscale that can manufacture nanostructures and erase mistakes.
July 07, 2020
In experiments in rats and mice, researchers have reported the successful use of nanoparticles to deliver gene therapy for wet age-related macular degeneration – an eye disease characterized by abnormal blood vessel growth that damages the retina.
June 29, 2020
By folding DNA into a virus-like structure, researchers have designed HIV-like nanoparticles that provoke a strong immune response from human immune cells grown in a lab dish. Such nanoparticles might eventually be used as an HIV vaccine.